- Home
- ACON vs INM Comparison
ACON vs INM Comparison
Compare ACON & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACON | INM |
|---|---|---|
| Founded | 2008 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 7.6M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACON | INM |
|---|---|---|
| Price | $2.35 | $1.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 41.1K | ★ 769.9K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $75,730.00 | ★ $4,942,633.00 |
| Revenue This Year | $87.22 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.62 | 7.50 |
| 52 Week Low | $1.95 | $0.58 |
| 52 Week High | $12.03 | $2.50 |
Technical Indicators
Market Signals| Indicator | ACON | INM |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 42.60 |
| Support Level | $1.95 | $1.09 |
| Resistance Level | $2.50 | $1.52 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 72.73 | 15.56 |
Price Performance
Historical ComparisonAbout ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.